J HEALTH ECON 润色咨询

JOURNAL OF HEALTH ECONOMICS

出版年份:1982 年文章数:2559 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:7.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1093283, encodeId=f8be1093283f0, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093284, encodeId=34521093284bf, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540130, encodeId=e318540130b3, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472315, encodeId=2e424e2315a8, content=请教!没有留言的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xh, createdTime=Thu Oct 28 23:01:00 CST 2010, time=2010-10-28, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    如何判断两种药物之间是协同作用还是相加作用?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1093283, encodeId=f8be1093283f0, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093284, encodeId=34521093284bf, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540130, encodeId=e318540130b3, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472315, encodeId=2e424e2315a8, content=请教!没有留言的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xh, createdTime=Thu Oct 28 23:01:00 CST 2010, time=2010-10-28, status=1, ipAttribution=)]
    2021-12-27 Mia

    如果文章发表了未提供ORCIDID如何添加?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1093283, encodeId=f8be1093283f0, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093284, encodeId=34521093284bf, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540130, encodeId=e318540130b3, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472315, encodeId=2e424e2315a8, content=请教!没有留言的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xh, createdTime=Thu Oct 28 23:01:00 CST 2010, time=2010-10-28, status=1, ipAttribution=)]
    2017-07-18 yang_liping1

    虽然今年没有什么大变化,以后再看看

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1093283, encodeId=f8be1093283f0, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093284, encodeId=34521093284bf, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=540130, encodeId=e318540130b3, content=虽然今年没有什么大变化,以后再看看, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_liping1, createdTime=Tue Jul 18 18:38:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=472315, encodeId=2e424e2315a8, content=请教!没有留言的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=xh, createdTime=Thu Oct 28 23:01:00 CST 2010, time=2010-10-28, status=1, ipAttribution=)]
    2010-10-28 xh

    请教!没有留言的……

    0

共7条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分